rxstat › Shortages › Aliskiren

Aliskiren shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Aliskiren has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 2
Reports on file
3

Reports by product

Resolved
RASILEZ
300MG · TABLET · NODEN PHARMA DAC
DIN 02302071 · ended Jun 8, 2024 · Shortage of an active ingredient.
Resolved
RASILEZ
150MG · TABLET · NODEN PHARMA DAC
DIN 02302063 · ended Jun 8, 2024 · Shortage of an active ingredient.
Resolved
RASILEZ
150MG · TABLET · NODEN PHARMA DAC
DIN 02302063 · ended Dec 27, 2023 · Shortage of an active ingredient.

What's happening

There are no active shortage reports for Aliskiren. Health Canada has 3 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Aliskiren is classified under “OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM” (ATC C09XA).

Recent changes

Common questions

When will Aliskiren be back in stock in Canada?

Aliskiren has no active shortage; supply is normal per Health Canada reports.

Why is Aliskiren in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.